missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18009919

Flt-3/Flk-2/CD135 Antibody (MM0294-9G23), DyLight 550, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-12311R

Product Code. 18009919

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
 View alternative products »

This item is not returnable. View return policy

Description

Description

Flt-3/Flk-2/CD135 Monoclonal specifically detects Flt-3/Flk-2/CD135 in Human samples. It is validated for Western Blot.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Flt-3/Flk-2/CD135
Monoclonal
DyLight 550
50mM Sodium Borate with 0.05% Sodium Azide
FLT3
Human recombinant Flt-3/Flk-2/CD135
0.1 mL
Primary
Human, Cynomolgus Monkey
Purified
Western Blot, Flow Cytometry
MM0294-9G23
Western Blot, Flow Cytometry
CD135, CD135 antigen, EC 2.7.10, fetal liver kinase 2, FL cytokine receptor, FLK2, FLT-3, FLT3 receptor tyrosine kinase, Fms-like tyrosine kinase 3, fms-related tyrosine kinase 3, growth factor receptor tyrosine kinase type III, Stem cell tyrosine kinase 1, STK-1, STK1EC 2.7.10.1, Tyrosine-protein kinase receptor FLT3
Mouse
Protein G purified
Cell Cycle and Replication, Phospho Specific
2322
Store at 4C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.